Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT01062230 · TERMINATED
Trial details
- NCT number
- NCT01062230
- Sponsor
- University of Arkansas
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2013-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.